Recent Updates
Recently added Catalysts
OM Positive Sentiment

Outset Medical to Report Third Quarter 2025 Financial Results on Monday, November 10, 2025

Key Takeaway: Outset Medical, a leader in dialysis technology, will announce its third quarter 2025 financial results on November 10, 2025. CEO Leslie Trigg and CFO Renee Gaeta will host a conference call to discuss these results. The company's Tablo® Hemodialysis System is recognized for its innovative approach to dialysis care.
Price reaction · baseline $14.38 (2025-10-27 close) · hit after-hours · clean, no other OM news in the window
day 0 close · peak
-1.2%

Market Sentiment Analysis

POSITIVE FACTORS

  • Outset Medical is pioneering innovative dialysis technology.
  • The upcoming financial results may indicate strong performance.
  • The company is trusted by over 1,000 healthcare facilities.

Full Press Release Details

SAN JOSE, Calif., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that it will release financial results for the third quarter 2025 after the close of trading on Monday, November 10, 2025.
On the same day, at 1:30 p.m. Pacific time (4:30 p.m. Eastern time), Leslie Trigg, Chair and Chief Executive Officer, and Renee Gaeta, Chief Financial Officer, will host a conference call to discuss financial and operating results.
Conference Call DetailsThe conference call will begin at 1:30 p.m. Pacific time (4:30 p.m. Eastern time) on Monday, November 10, 2025. Those interested in joining the conference call may do so byregistering online. Once registered, participants will receive dial-in numbers and a unique pin to join the call. Participants are encouraged to register more than 15 minutes before the start of the call. A live and archived webcast of the event will be available on the “Investors” section of the Outset website athttps://investors.outsetmedical.com/.
About Outset Medical, Inc.Outset is a medical technology company transforming the dialysis experience across the continuum of care with a first-of-its-kind technology. The Tablo® Hemodialysis System, FDA-cleared for use from hospital to home, is trusted by more than 1,000 U.S. healthcare facilities and has enabled millions of treatments delivered by thousands of nurses. Designed to reduce the cost and complexity of dialysis, Tablo combines water purification and on-demand dialysate production into a single, integrated system that connects seamlessly with Electronic Medical Record systems and a proprietary data analytics platform. This enterprise solution empowers providers to develop an in-house dialysis program where they are in control – enabling better operational, clinical, and financial outcomes. Outset is redefining what’s possible in kidney care through innovation, scale, and a relentless commitment to improving the lives of patients and the professionals who care for them. For more information, visitwww.outsetmedical.com.

Frequently Asked Questions

When will Outset Medical release its Q3 2025 results?

Outset Medical will release its Q3 2025 financial results on November 10, 2025.

Who will host the conference call for the financial results?

Leslie Trigg, CEO, and Renee Gaeta, CFO, will host the conference call.

What is the Tablo® Hemodialysis System?

The Tablo® Hemodialysis System is an innovative technology for dialysis care.

How can I join the conference call?

Participants can register online to receive dial-in numbers and a unique pin.

Last updated: Oct 27, 2025